|
Balu, Narayanan; Gamcsik, Michael P; Colvin, Michael E et al. (2002) Modified guanines representing O(6)-alkylation by the cyclophosphamide metabolites acrolein and chloroacetaldehyde: synthesis, stability, and ab initio studies. Chem Res Toxicol 15:380-7
|
|
Wu, M H; Liebowitz, D N; Smith, S L et al. (2001) Efficient expression of foreign genes in human CD34(+) hematopoietic precursor cells using electroporation. Gene Ther 8:384-90
|
|
Long, L; Moschel, R C; Dolan, M E (2001) Debenzylation of O(6)-benzyl-8-oxoguanine in human liver: implications for O(6)-benzylguanine metabolism. Biochem Pharmacol 61:721-6
|
|
Wu, M H; Smith, S L; Danet, G H et al. (2001) Optimization of culture conditions to enhance transfection of human CD34+ cells by electroporation. Bone Marrow Transplant 27:1201-9
|
|
Ewesuedo, R B; Dolan, M E (2000) Pharmacokinetics of oral O6-benzylguanine and evidence of interaction with oral ketoconazole in the rat. Cancer Chemother Pharmacol 46:150-5
|
|
Gamcsik, M P; Dolan, M E; Andersson, B S et al. (1999) Mechanisms of resistance to the toxicity of cyclophosphamide. Curr Pharm Des 5:587-605
|
|
Cai, Y; Wu, M H; Ludeman, S M et al. (1999) Role of O6-alkylguanine-DNA alkyltransferase in protecting against cyclophosphamide-induced toxicity and mutagenicity. Cancer Res 59:3059-63
|
|
Wu, M H; Lohrbach, K E; Olopade, O I et al. (1999) Lack of evidence for a polymorphism at codon 160 of human O6-alkylguanine-DNA alkyltransferase gene in normal tissue and cancer. Clin Cancer Res 5:209-13
|
|
Long, L; McCabe, D R; Dolan, M E (1999) Determination of 8-oxoguanine in human plasma and urine by high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Sci Appl 731:241-9
|
|
Dolan, M E; McRae, B L; Ferries-Rowe, E et al. (1999) O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents. Clin Cancer Res 5:2059-64
|
Showing the most recent 10 out of 12 publications
